Total Clarity Wealth Management’s Gilead Sciences GILD Stock Holding History

Total Clarity Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,807	Closed	-$112K	–	508
2022 Q2	$112K	Buy	+1,807	New	+$112K	0.06%	303
2022 Q1	–	Sell	-831	Closed	-$60K	–	475
2021 Q4	$60K	Buy	831 +67	+9%	+$4.62K	0.03%	374
2021 Q3	$53K	Buy	+764	New	+$53.7K	0.03%	394
2021 Q2	–	Sell	-964	Closed	-$62K	–	382
2021 Q1	$62K	Buy	+964	New	+$62.2K	0.04%	307
2020 Q1	–	Sell	-290	Closed	-$19K	–	276
2019 Q4	$19K	Buy	+290	New	+$18.9K	0.01%	400

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Total Clarity Wealth Management's GILD Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 1,807 shares — an estimated $112K sold.

Total Clarity Wealth Management first reported a position in GILD in Q4 2019 and held it in 5 quarters. The position peaked at $112K in Q2 2022. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

Total Clarity Wealth Management reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 1,807 Gilead Sciences shares in Q3 2022, an estimated $112K.
Total Clarity Wealth Management first reported a position in Gilead Sciences in Q4 2019 and held it in 5 quarters.
Total Clarity Wealth Management's Gilead Sciences position peaked at $112K in Q2 2022.
1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.